Navigation Links
Growing Supply Chain Complexity Increasing Impact on Medical Device Company Operations
Date:10/13/2009

s its customers a complete solution for global quality management needs, including the onsite support required throughout the project lifecycle. More information about Sparta Systems and TrackWise software can be found at www.spartasystems.com.

Sparta Systems and TrackWise are trademarks or registered trademarks of Sparta Systems, Inc. All other marks are trademarks of their respective companies. 

    PR Contacts:
    Jon Rabinowitz
    Director of Marketing
    Sparta Systems, Inc.
    Tel: 732.203.0400, ext. 121
    jon.rabinowitz@spartasystems.com

    Katy Zack
    Articulate Communications Inc.
    Tel: 212.255.0080, ext. 11
    kzack@articulatepr.com

SOURCE Sparta Systems, Inc.


'/>"/>
SOURCE Sparta Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Sigma-Aldrich(R) Partners With Flow Chemistry Leader ThalesNano to Provide CatCart(R) Catalyst Products for Rapidly Growing Market
2. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
3. invivodata Recognized as One of Pittsburghs Fastest Growing Private Companies
4. Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
5. Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
6. TriLink BioTechnologies, Inc. Announces Supply Agreement With Osmetech Molecular Diagnostics
7. New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nations Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
8. Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator
9. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
10. Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized Moderate Complexity by FDA
11. Abbotts Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,, BASKINGRIDGE,N.J.,Nov.25/PRNewswire/--Rega...opmentofantithromboticaptamerswithactivecontrolage...llbepresentingatthePiperJaffray21stAnnualHealthCar....Mazzo,spresentationwillbegivenat1:10pm(EST)onTues...spipelinewithemphasisontheleaddevelopmentprogram,t...
(Date:11/25/2009)...,, UNIONCITY,Calif.,Nov.25/PRNewswire-FirstCa...mpanymanufacturingpoint-of-carebloodanalysissystem...executiveofficer,willpresentatthe21stAnnualPiperJa...9at2:00p.m.ET.TheconferencewillbeheldattheNewYorkP... Abaxisdevelops,manufacturesandmarketsportablebloo...
(Date:11/25/2009)...,, CHAPELHILL,N.C.,Nov.25/PRNewswire/--Cempra...rnandes,presidentandchiefexecutiveofficer,willpres...at8:50a.m.EST,December1,2009,atTheNewYorkPalaceHot...fthecompany,stwoleadingantibioticclinicalprogramsf...SA. ,, AboutCempraPharmaceuticals ,, Found...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2ADVENTRX Pharmaceuticals Announces Plans for Remainder of 2009 12824 1ADVENTRX Pharmaceuticals Announces Plans for Remainder of 2009 12824 2ADVENTRX Pharmaceuticals Announces Plans for Remainder of 2009 12824 3Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cutaneous T cell Lymphoma 12823 1Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cutaneous T cell Lymphoma 12823 2Presagia Launches Web Based Employee Leave Solution With Automated FMLA Workflow 50260 1Presagia Launches Web Based Employee Leave Solution With Automated FMLA Workflow 50260 2Presagia Launches Web Based Employee Leave Solution With Automated FMLA Workflow 50260 3
...N, DC, June 11, 2007 /PRNewswire-FirstCall/ - Paul...ne at Georgetown,University Medical Center, and pr...chem Inc.,s North American Phase III clinical tria...ay an update on,Neurochem,s investigational produc...se (AD). The presentation by Dr. Aisen will take,p...
...tabine achieved both primary and secondary endpoin... observed between,valopicitabine and ribavirin ~, ...all/ -- Idenix,Pharmaceuticals, Inc. today announc...ate triple combination therapy, consisting of,valo...or the,treatment of hepatitis C, pegylated interfe...
Other Medicine Technology:At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 2At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 3At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 2Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 3Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 5Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 6
(Date:11/25/2009)... who were treated with cisplatin-based chemotherap...ical side effects and Raynaud-like phenomena, than...ding to a new study published online November 25 i..., Marianne Brydy, M.D., of the Department of Onc...orway, and colleagues conducted a cross-sectional ...
(Date:11/25/2009)...d arthritis, could help newly diagnosed diabetics,...lthDay News) -- A drug commonly used to treat non-...so shows some promise in helping patients newly di...imab (Rituxan), helped patients keep producing som...d destroyed some of their pancreatic beta cells, w...
(Date:11/25/2009)...ONSkincare ®isproudtosupportGNC,seffortstorai...t.Jude ThanksandGiving campaign,$1fromthepurchasep...Balm willbedonatedtoSt.Jude.Additionally,GNCcustom...eckoutatoneoftheir5,000+retaillocationsoratGNC.com...heir2009 ThanksandGiving campaign. ,, "Wearedel...
(Date:11/25/2009)...ccur in children with autism and related condition...es medication combined with a structured training ...researchers and their colleagues. , Published i...merican Academy of Child and Adolescent Psychiatry...te of Mental Health (NIMH) Research Units on Pedia...
(Date:11/25/2009)...e premier resource for life science careers and in...rest™ Hotbed Campaign this morning. , ...25, 2009 -- BioSpace.com, the premier resource for...e third edition of the BioForest™ Hotbed Cam...n is a promotional effort highlighting biotechnolo...
Breaking Medicine News(10 mins):Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2
... across the Yangtze River will take another two ye...ready changing the local weather, claim scientists... data suggest that the reservoir is cooling the Ya...ty of Maryland in College Park have collaborated w...
...consider home to be the safest place for deliverie...t their children immunised. The Gandhi M...egions of Udaipur district, conducted the study of...ording to the findings, around 94 percent of pregn...
...ons of insect love and desire. The cicada's songs ... how an emitting sex attracts conspecific members...though less conspicuous for us humans, are also si...thought to play a major role in the evolution of m...
..., Volodymyr Tarabara and Tom Voice, are leading an... Tarabara and Voice are leading an internatio...entists from two U.S. research universities, two r...nding of its kind a $2.5 million grant by the Na...
...e of humour or great look is whats really needed t...sing skills . A poll by online dating agenc...umped a lover because they were a miserable kisser... relationship. This was followed by using ...
...s drug dealer has revealed secrets about the singe... The singer and McFadden Kitten split two years ag... daughters Molly, 4, and Lilly Sue, 3. A...out drugs than anything in her life her children,...
Other Medicine News:Health News:China's Three Gorges Dam Changing Local Weather: Scientists 2Health News:Poor Health Practices Plague Rajasthan Tribal Women 2Health News:Another Sexual Attraction is Possible ... 2Health News:Two MSU Professors Spearhead International Water Project 2Health News:Two MSU Professors Spearhead International Water Project 3Health News:Drugs More Important Than Kids for Katona, Says Her Candy Man 2
...ities where space is a premium Fabius Tiro combine...gies with an ergonomic and compact design. Adding ...nfinity patient monitoring range allows you to cre...nd investment into the future. The open modular ar...
... using Datex-Ohmedas unique approach to anesthesia...laboration with clinicians. It combines the proven...eda monitoring technology into an affordable syste...world, ,The contemporary, compact design addresse...
...nt Wound Dressing is a sterile, single use bundle ...g applications. The synthetic matrix absorbs exce...ontours, and entraps slough and necrotic debris wi...rands of the matrix are bound together by a matrix...
...sician preference card system as well as a perpetu...management requirements of the surgical services d...h a broad array of inventory management capabiliti...e supply and charge capture workflow. Regardless o...
Medicine Products: